ARAY
Accuray Incorporated
NASDAQ: ARAY · HEALTHCARE · MEDICAL DEVICES
$0.31
-6.46% today
Updated 2026-06-05
Market cap
$31.48M
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $2
Volume
3.8M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
2.7
Growth
F3.5
Quality
D2.0
Profitability
F4.0
Valuation
C5/9
Piotroski F-Score
Moderate
-0.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
$0.35
+11.86%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Altman Z -0.03 — distress zone
- Thin margins at -10.80%
- Negative free cash flow $-7.11M
- Revenue declining -7.40% QoQ
- Debt/equity 4.37x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $429.91M | $447.61M | $446.55M | $458.50M | $428.57M |
| Net income | $-5.35M | $-9.28M | $-15.54M | $-1.59M | $-11.80M |
| EPS | — | — | — | — | $-0.38 |
| Free cash flow | $-7.12M | $2.86M | $-15.51M | $-5.66M | $-7.11M |
| Profit margin | -1.24% | -2.07% | -3.48% | -0.35% | -10.80% |
Peer comparison
Smart narrative
Accuray Incorporated trades at $0.31. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -0.03, it sits in the distress. TTM revenue stands at $428.57M. with profit margins at -10.80%.
Frequently asked questions
What is Accuray Incorporated's stock price?
Accuray Incorporated (ARAY) trades at $0.31, on a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Accuray Incorporated overvalued?
Accuray Incorporated carries a Smart Value Score of 35/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Accuray Incorporated (ARAY)?
The 12-month analyst consensus target is $0.35, about 11.9% above the current $0.31. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Accuray Incorporated's revenue?
Accuray Incorporated's trailing twelve-month revenue is $428.57M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Accuray Incorporated's Altman Z-Score is -0.03, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.07x
ROE-110.60%
Beta1.35
50D MA$0.37
200D MA$0.83
Shares out0.12B
Float0.11B
Short ratio—
Avg volume3.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—